Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L23a pseudogene 95 (RPL23AP95)
- Target
- RPL23AP95
- Molecular classification
- Other (pseudogene)
01
Overview
Ribosomal protein L23a pseudogene 95 (RPL23AP95) is one of at least 95 processed pseudogenes related to the ribosomal protein L23a, a component of the 60S subunit of the cytoplasmic ribosome[3]. Pseudogenes are segments of DNA that resemble functional genes but have lost their protein-coding ability or are otherwise nonfunctional as genes. There is no evidence that RPL23AP95 is transcribed, encodes a functional RNA or protein, or has any direct effect on cell biology or disease. Most scientific investigation and any potential biological or diagnostic role has focused on RPL23A itself or other specific RPL23A pseudogenes, such as RPL23AP53[1][3]. No published information was found describing RPL23AP95 specifically as a therapeutic target, nor is it recognized for biomarker, drug interaction, or functional roles[1][3]. If you are seeking information about a functionally relevant molecule or potential therapeutic target, RPL23AP95 is not appropriate.
- Other names
- RPL23AP95Ribosomal protein L23a pseudogene 95
02
Mechanism of action
None known
03
Biological functions
Other (no demonstrated biological function; see below for rationale)
04
Disease associations
Other (no direct disease role established for RPL23AP95; see below)
Beyond the preview
Go deeper on Ribosomal protein L23a pseudogene 95 (RPL23AP95).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ribosomal protein L23a pseudogene 95 (RPL23AP95).